The Securities and Exchange Commission (SEC) has reached a settlement in its latest insider trading case involving confidential merger information obtained from Covington & Burling LLP. The agreement involves Philip Markin, a New Jersey resident, who has agreed to pay almost $33,000 after being accused of leveraging non-public information to engage in profitable trading.
According to the SEC filing, Markin acquired this sensitive information from a Covington associate engaged in Merck & Co.’s $1.85 billion acquisition of Pandion Therapeutics. Markin was able to earn over $16,000 by purchasing Pandion stock prior to the public announcement of the deal in February 2021.
This case underscores the ongoing vigilance of the SEC in monitoring and addressing insider trading activities linked to confidential corporate transactions. Legal professionals and corporate counsel should note the increased scrutiny and potential legal ramifications for unlawful use of non-public information.
The settlement follows a pattern of rigorous enforcement by the SEC to maintain market integrity, particularly concerning the misuse of critical information in mergers and acquisitions. For more details, access the full article.